Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Return on Sales (2016 - 2025)

Historic Return on Sales for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to 0.16%.

  • Prestige Consumer Healthcare's Return on Sales fell 500.0% to 0.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.17%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.19% for FY2025, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Return on Sales is 0.16%, which was down 500.0% from 0.15% recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Return on Sales ranged from a high of 0.21% in Q2 2021 and a low of 0.84% during Q1 2023
  • In the last 5 years, Prestige Consumer Healthcare's Return on Sales had a median value of 0.19% in 2024 and averaged 0.13%.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Return on Sales plummeted by -10400bps in 2023, and later surged by 10200bps in 2024.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Return on Sales stood at 0.18% in 2021, then rose by 3bps to 0.19% in 2022, then fell by 0bps to 0.19% in 2023, then rose by 12bps to 0.21% in 2024, then decreased by -22bps to 0.16% in 2025.
  • Its Return on Sales stands at 0.16% for Q4 2025, versus 0.15% for Q3 2025 and 0.19% for Q2 2025.